Neurogenesis is the generation of neurons from stem and progenitor cells. The majority of neurogenesis occurs in pre-natal development, but recent research has found neurogeneration to occur in adults in two regions of the brain: the subventricular zone of the lateral ventricles, which ultimately lead to the olfactory bulb, and the subgranular zone of the dentate gyrus located in the hippocampus. The majority of these new neurons die quickly after generation, but some are able to migrate into the surrounding brain tissue. The rate of successful neurogenesis depends on several factors including testosterone, exercise, CNS injuries, and chronic stress. Neurogenesis has been shown to have a positive effect on memory retention and capacity as well as on the side effects of stress.
Neurogenesis Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Neurogenesis below!
For more information on how to use Laverne, please read the How to Guide.
We have 1654 products for the study of the Neurogenesis Pathway that can be applied to Western Blot, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.